Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, Zhang X, Birk A, Chang J, Shi PY, Block TM, Guo JT.

J Virol. 2010 Aug;84(16):8332-41. doi: 10.1128/JVI.02199-09. Epub 2010 Jun 9.

2.

The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling.

Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, Rockx B, Liu W, Ashour J, Shupert WL, Holbrook MR, Barrett AD, Mason PW, Bloom ME, García-Sastre A, Khromykh AA, Best SM.

J Virol. 2010 Apr;84(7):3503-15. doi: 10.1128/JVI.01161-09. Epub 2010 Jan 27.

3.

Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation.

Mazzon M, Jones M, Davidson A, Chain B, Jacobs M.

J Infect Dis. 2009 Oct 15;200(8):1261-70. doi: 10.1086/605847.

4.

NS5 of dengue virus mediates STAT2 binding and degradation.

Ashour J, Laurent-Rolle M, Shi PY, García-Sastre A.

J Virol. 2009 Jun;83(11):5408-18. doi: 10.1128/JVI.02188-08. Epub 2009 Mar 11.

5.

Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor.

Liu J, HuangFu WC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs SY.

Cell Host Microbe. 2009 Jan 22;5(1):72-83. doi: 10.1016/j.chom.2008.11.008.

6.

Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.

Kumar KG, Varghese B, Banerjee A, Baker DP, Constantinescu SN, Pellegrini S, Fuchs SY.

J Biol Chem. 2008 Jul 4;283(27):18566-72. doi: 10.1074/jbc.M800991200. Epub 2008 May 12.

7.

Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay.

Kaleem A, Ahmad I, Hoessli DC, Walker-Nasir E, Saleem M, Shakoori AR, Nasir-Ud-Din.

Mol Biol Rep. 2009 Apr;36(4):631-9. doi: 10.1007/s11033-008-9223-6. Epub 2008 Mar 14.

PMID:
18340549
8.

Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis.

Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL, Fuchs SY.

J Cell Biol. 2007 Dec 3;179(5):935-50.

9.

The continuing spread of West Nile virus in the western hemisphere.

Gubler DJ.

Clin Infect Dis. 2007 Oct 15;45(8):1039-46. Epub 2007 Sep 14. Review.

10.
11.

West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis.

Medigeshi GR, Lancaster AM, Hirsch AJ, Briese T, Lipkin WI, Defilippis V, Früh K, Mason PW, Nikolich-Zugich J, Nelson JA.

J Virol. 2007 Oct;81(20):10849-60. Epub 2007 Aug 8.

12.
13.
15.

Interferon signalling network in innate defence.

Takaoka A, Yanai H.

Cell Microbiol. 2006 Jun;8(6):907-22. Review.

PMID:
16681834
16.

TYK2 activity promotes ligand-induced IFNAR1 proteolysis.

Marijanovic Z, Ragimbeau J, Kumar KG, Fuchs SY, Pellegrini S.

Biochem J. 2006 Jul 1;397(1):31-8.

18.

Role of the unfolded protein response in cell death.

Kim R, Emi M, Tanabe K, Murakami S.

Apoptosis. 2006 Jan;11(1):5-13. Review.

PMID:
16374548
19.

Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.

Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, Boer E, Wolfinbarger JB, Bloom ME.

J Virol. 2005 Oct;79(20):12828-39.

20.

Virology, pathology, and clinical manifestations of West Nile virus disease.

Hayes EB, Sejvar JJ, Zaki SR, Lanciotti RS, Bode AV, Campbell GL.

Emerg Infect Dis. 2005 Aug;11(8):1174-9. Review.

Items per page

Supplemental Content

Write to the Help Desk